Live Analyst Rating Changes 36973 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Christopher Kuplent
BofA

Christopher Kuplent

Bank of America Securities
Wall Street Analyst
★★☆☆☆
#2793
on 13Foresight · ranked by our own returns
50%
Success Rate
-0.4%
Average Return
16 of 32 calls profitable · +20.3% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 50% of Christopher Kuplent's ratings turned a profit when each position was held for 1 year — averaging -0.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

20 Buy 22 Hold 13 Sell
Christopher's Stock Coverage 17 ratings · 2026-10-05
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
GB:BP
BP p.l.c.
 Oct 02, 2026 SELL Strong Buy
+316.5% avg upside
30 analysts
$510.00
8.53% Downside
 · ·
FR:TTE
TotalEnergies SE
 Oct 02, 2026 BUY Buy
+7.3% avg upside
28 analysts
$88.00
18.25% Upside
 · ·
GB:0M2Z
Equinor ASA
 Oct 02, 2026 BUY Sell
-15.6% avg upside
26 analysts
$480.00
19.11% Upside
 · ·
GB:SHEL
Shell (UK)
 Oct 02, 2026 HOLD Strong Buy
+369.7% avg upside
27 analysts
$3600.00
0.11% Upside
 · ·
EQNR
Equinor ASA
 Sep 18, 2026 BUY Hold
+31.2% avg upside
16 analysts
$48.24
13.32% Upside
 -5.7% ·
IT:ENI
ENI S.p.A.
 Sep 09, 2026 HOLD Buy
-10.1% avg upside
23 analysts
$24.00
0.84% Downside
 +1.7% ·
BP
BP
 Aug 05, 2026 SELL Buy
+2.5% avg upside
31 analysts
$37.00
17.41% Downside
 -10.0% ·
E
Eni SPA
 Jul 30, 2026 HOLD Buy
-49.7% avg upside
16 analysts
 — -0.9% ·
SHEL
Shell
 Dec 05, 2025 HOLD Strong Buy
-11.0% avg upside
27 analysts
$41.03
57.44% Downside
 +34.5% ·
GB:0O46
Neste Corporation
 Sep 26, 2025 SELL Buy
+3.5% avg upside
20 analysts
$16.00
49.35% Downside
 · ·
IT:TEN
Tenaris
 Jul 21, 2025 SELL Buy
-29.8% avg upside
12 analysts
$16.00
35.32% Downside
 -65.5% ·
TS
Tenaris SA
 Feb 21, 2025 SELL Buy
-19.7% avg upside
23 analysts
 — -43.1% ·
GB:0OGK
Subsea 7
 Jan 29, 2025 SELL Buy
+0.9% avg upside
17 analysts
$190.00
40.31% Downside
 -42.1% ·
IT:SPM
Saipem SpA
 Jan 29, 2025 BUY Strong Buy
-5.6% avg upside
14 analysts
$3.50
18.96% Downside
 +43.2% ·
FR:VK
Vallourec
 Jan 29, 2025 HOLD Strong Buy
+23.6% avg upside
7 analysts
$20.00
11.87% Upside
 +8.1% ·
ES:REP
Repsol
 Dec 07, 2023 SELL Buy
-25.7% avg upside
22 analysts
$12.00
58.70% Downside
 +13.7% ·
GB:0B67
GALP Energia SGPS
 Dec 07, 2023 SELL Buy
-5.6% avg upside
16 analysts
$9.00
58.36% Downside
 -25.3% ·
🔒 12 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Christopher Kuplent — Frequently Asked Questions
How accurate are Christopher Kuplent's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Christopher's ratings were profitable over a one-year hold, with an average return of -0.4% per rating, or +20.3% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Christopher ranked on 13Foresight?
Christopher Kuplent is currently ranked #2793 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Christopher cover?
Christopher most recently has ratings on GB:BP, FR:TTE, GB:0M2Z, GB:SHEL, EQNR, IT:ENI, BP, E, SHEL, GB:0O46, IT:TEN, TS and 5 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.